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Study Design 
A Cochrane Systematic Review 
Objective 
To evaluate the efficacy of bracing for adolescents with AIS versus no treatment or other treatments, on quality 
of life, disability, pulmonary disorders, progression of the curve, psychological and cosmetic issues. 
Summary of Background Data  
Idiopathic scoliosis is a three-dimensional deformity of the spine. The most common form is diagnosed in 
adolescence. While adolescent idiopathic scoliosis (AIS) can progress during growth and cause a surface 
deformity, it is usually not symptomatic.  
Methods  
Search methods 
We searched CENTRAL, MEDLINE, EMBASE, five other databases, and two trials registers up to February 
2015. We also checked reference lists and hand searched grey literature. 
Selection criteria 
RCTs and prospective controlled cohort studies comparing braces with no treatment, other treatment, surgery, 
and different types of braces for adolescent with AIS. 
Data collection and analysis 
We used standard methodological procedures expected by The Cochrane Collaboration. 
Results 
We included seven studies. Five were planned as RCTs, two as prospective CCT`s. One RCT failed completely, 
another was continued as an observational study. There was very low quality evidence from one small RCT that 
quality of life (QoL) during treatment did not differ significantly between rigid bracing and observation. 
Conclusions 
Two studies showed that bracing did not change QoL during treatment, and QoL, back pain psychological and 
cosmetic issues in the long term (16 years.) All papers showed that bracing prevented curve progression. The 
high rate of failure of RCTs demonstrates the huge difficulties in performing RCTs in a field where parents 
reject randomization of their children.  
Key Words: Braces, adolescents, idiopathic, scoliosis, systematic review, observation, physical therapy 
Level of Evidence: 1 
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Background 
Description of the condition 
Scoliosis is a three-dimensional deformity of the spine and the trunk [1]. The most common form is idiopathic 
scoliosis (70% to 80% of cases) [1,2]. Adolescent idiopathic scoliosis (AIS) is discovered at 10 years of age or 
older [2], and is defined as a curve of at least 10°, measured on a standing radiograph using the Cobb technique 
[1]. While the prevalence of AIS is 0.9% to 12% in the general population [3], almost 10% of people diagnosed 
with AIS will require some form of treatment. Furthermore, up to 0.1% of the population is at risk of surgery 
[4,5]. A severe form of AIS is more commonly found in females (80% to 90%). Typically, AIS does not cause 
any health problems during growth (except for extreme cases). However, the resulting surface deformity 
frequently has a negative impact on adolescents that can give rise to quality of life (QoL) issues and in the most 
severe cases, psychological disturbances [6,7]. Adolescents are generally treated in an attempt to halt the 
progressive nature of the deformity. No treatments succeed in full correction to a normal spine, and even 
reduction of the deformity is difficult [4,8]. If scoliosis surpasses a critical threshold, usually considered to be 
30° Cobb, at the end of growth, the risk of health problems in adulthood increases significantly [4,9,10]. 
Problems include reduced QoL, disability, pain, increased cosmetic deformity, functional limitations, pulmonary 
problems, and possible progression during adulthood [8–17]. Because of this, management of scoliosis also 
includes the prevention of secondary problems associated with the deformity [18]. 
Description of the intervention 
Treatment options for the prevention of AIS progression include exercises, bracing, and surgery [1,19–29]. 
Bracing can be defined as the application of external corrective forces to the trunk. This is usually achieved 
through rigid supports, but elastic bands are also used [30]. Treatment commences when the curve is diagnosed 
as progressive or exceeds a threshold, which is considered to be above 20° Cobb, usually between 25° and 30°  
[4,22,31]. Braces should generally be worn full-time (at least 20 hours per day) with treatment usually lasting 
from a minimum of two to four or five years, until the end of bone growth [32–35]. All this causes a significant 
impact on the lives of children and adolescents [36–40]. 
How the intervention might work 
The mechanical forces and the external and proprioceptive inputs of bracing can reduce unnatural loading and 
asymmetrical movements and improve neuromuscular control. This facilitates proper spinal growth, neuromotor 
re-organization, and change of motor behaviours [13,38,41–46]. 
Why it is important to do this review 
Currently, the bracing of adolescents with AIS is controversial. It is considered standard treatment in continental 
Europe, but not in many centres of the UK, US, and elsewhere [2,47]. Bracing has been widely criticized 
because there is a paucity of evidence regarding its benefits [48–52]. Moreover, bracing has been linked to 
reduced QoL and increased psychological issues [36,37,39,40]. To date, reviews on braces have been mainly 
narrative, have not considered the key issue of evaluating the methodological quality of the studies in the review, 
and have not included all existing studies [20,29,51]. Our previous Cochrane review was based on only two 
studies and found inconclusive evidence [53]. An update of this review will help clinicians to decide whether the 
sacrifices required by children to wear braces are indeed worthwhile. 
Objectives 
To evaluate the efficacy of bracing for adolescents with AIS versus no treatment or other treatments, on quality 
of life, disability, pulmonary disorders, progression of the curve, and psychological and cosmetic issues. 
Methods 
Criteria for considering studies for this review 
Types of studies 
All randomized controlled trials (RCTs) and prospective controlled cohort studies. 
Types of participants 
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We included all participants who were 10 years of age or older (until the end of bone growth) when diagnosed as 
having AIS. We included only studies in which bone maturity was evaluated by the Risser sign, wrist 
radiographs, or both. We excluded studies in which participants presented with any type of secondary scoliosis 
(congenital, neurological, metabolic, post-traumatic, etc.) diagnosed according to the Scoliosis Research Society 
(SRS) [35], and the international Society on Scoliosis Orthopedic and Rehabilitation Treatment (SOSORT) [1], 
criteria. 
Types of interventions 
We included all types of rigid, semi-rigid, and elastic braces (defined as devices to apply external corrective 
forces to the spine and trunk), worn for a specific number of hours per day for a specific number of years. We 
considered all possible control interventions and comparisons. 
Types of outcome measures 
Primary outcomes 
Pulmonary disorders, disability, back pain, QoL, and psychological and cosmetic issues. We included only 
validated measures of study outcomes, and we assessed minimal clinically important differences on a case-by-
case basis. 
Secondary outcomes 
Clinical and radiographic parameters [1,9]. Very short (any result before the end of bone growth), intermediate 
(results at the end of bone growth), and long-term (results in adulthood) outcomes. Progression of scoliosis was 
measured by: 
• Cobb angle in degrees (absolute values); 
• number of participants who had progressed by more than 5° Cobb (radiographic measurement error, considered 
as the minimal clinically important difference) [1]; 
• risk of success, defined in terms of participants that at the end of treatment were neither treated surgically 
(fused) nor surpassing specific thresholds considered clinically meaningful (45° or 50°, or both) [1,31]; 
• Adverse effects, as outlined in identified trials. 
Search methods for identification of studies 
Electronic searches 
For this update, we searched the following electronic databases to 17 and 18 February 2015 to identify relevant 
studies: 
• the Cochrane Register of Controlled Trials (CENTRAL, The Cochrane Library, which includes Cochrane 
Back Review Group Trials Register; Issue 1 of 12, January 2015); 
• MEDLINE (Ovid SP, 1946 to February week 2 2015); 
• MEDLINE In-Process & Other Non-Indexed Citations (Ovid SP, 13 February 2015); 
• EMBASE (Ovid SP, 1980 to week 7 2015); 
• Cumulative Index to Nursing and Allied Health Literature (CINAHL; EBSCO, 1981 to 18 February 2015); 
• PsycINFO (Ovid SP, 2002 to February week 2 2015); 
• Physiotherapy Evidence Database (PEDro); 
• Cochrane Back Review Group Trials Register (Reference Manager and Cochrane Register of Studies (CRS)); 
• ClinicalTrials.gov; 
• World Health Organization (WHO) International Clinical Trials Registry Platform (WHO ICTRP); 
• PubMed. 
As with the original review, we used the search strategies recommended by the Cochrane Back Review Group 
for the identification of RCTs [54], and adapted them to include cohort studies. The Cochrane Back Review 
Group Trials Search Co-ordinator developed the strategies and used a combination of controlled vocabulary 
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terms (e.g. MeSH terms) and keywords to describe methodology, disorders, and treatment. These methods were 
consistent with the Chapter 6 of the Cochrane Handbook for Systematic Reviews of Interventions [55] 
. Appendix 1, Appendix 2, and Appendix 3 show the strategies for each database. 
Searching other resources 
We also included the following strategies: 
• reference lists of all relevant papers; 
• main electronic sources of ongoing trials (National Research Register, meta-Register of Controlled Trials; 
Clinical Trials); 
• grey literature, including conference proceedings, PhD theses, and unpublished work conducted by 
manufacturers that were likely to contain trials relevant to the review; 
• contacted investigators and authors in this field for information on unpublished or incomplete trials. 
All searches included non-English language studies. When considered likely to meet inclusion criteria, we 
translated studies published in languages other than English. 
Data collection and analysis 
Selection of studies 
Two review authors (JBS, NC) independently evaluated the search results by reading the titles; two other review 
authors (TB, TM) independently reviewed the abstracts of the remaining papers. We obtained potentially 
relevant studies in full text and two review authors (TK, FZ) independently assessed them for inclusion. None of 
the papers was reviewed by any of the authors who may have written the original papers. At all stages, we 
resolved disagreements through discussion. The lead review author (SN) solved any persisting disagreements. 
Data extraction and management 
We prepared a standardized data extraction form, which we used to extract data from the included papers. Two 
review authors (SM, FZ) independently extracted data on the population, study characteristics, and results added 
to Review Manager 5.3. We discussed any disagreements, and consulted the lead review author (SN) if 
disagreements persisted. We summarized key findings in a narrative format and assessed for inclusion in a meta-
analysis where possible. 
Clinical relevance of results 
The review authors assessed each trial for its clinical relevance by using the five questions outlined by Shekelle 
1994 [56], and recommended by the Cochrane Back Review Group [54]. We assessed all important outcomes for 
each comparison. The main conclusions were clinical, because our main aim was to give clinicians state-of-the-
art information, according to relevant studies on this issue. 
Assessment of risk of bias in included studies 
We assessed the risk of bias of RCTs and controlled clinical trials (CCTs) in this review using the 12 criteria 
recommended by the Cochrane Back Review Group [54,55]. We used the Newcastle-Ottawa Scale (NOS scale) 
to assess the prospective cohort studies with a control group [57]. The NOS scale assesses three broad areas: 
selection bias, attrition bias, and detection bias. For each included study, each type of bias was rated as high, 
low, or unclear and entered into the risk of bias table (Figure 1 - 2). 
Two review authors, one with methodological expertise and one with content expertise, independently assessed 
the risk of bias of the included studies. The review authors resolved any disagreements by discussion, including 
input from a third independent review author if required. Risk of bias assessment was not blinded to trial authors, 
institution, or journal. 
Measures of treatment effect 
We analysed dichotomous outcomes by calculating the risk ratio (RR) for each trial, with the uncertainty in each 
result expressed with 95% confidence intervals (CI). We analysed continuous outcomes by calculating the mean 
difference (MD) or the standardized mean difference (SMD) with 95% CI. 
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Data synthesis 
Meta-analysis was not performed because the retrieved studies were too heterogeneous with regards to the study 
design, types of comparisons, populations included, and braces applied (elastic, rigid, very rigid). Therefore, we 
did not perform the pre-planned investigations of heterogeneity, sensitivity analysis excluding studies with high 
risk of bias, and subgroup analysis for studies at low risk of bias. We assessed the overall quality of the evidence 
for each outcome. We used an adapted GRADE approach, as recommended by the Cochrane Back Review 
Group [54]. Factors that may decrease the quality of the evidence are study design and risk of bias, inconsistency 
of results, indirectness (not generalizable), imprecision (sparse data), and other factors (e.g. reporting bias and 
publication bias). The quality of the evidence for a specific outcome was downgraded by a level, according to 
the performance of the studies against these five factors. 
• High quality evidence: there are consistent findings among at least 75% of RCTs with low risk of bias, 
consistent, direct, and precise data and no known or suspected publication biases. Further research is unlikely 
to change either the estimate or our confidence in the results. 
• Moderate quality evidence: one of the domains is not met. Further research is likely to have an important 
impact on our confidence in the estimate of effect and may change the estimate. 
• Low quality evidence: two of the domains are not met. Further research is very likely to have an important 
impact on our confidence in the estimate of effect and is likely to change the estimate. 
• Very low quality evidence: three of the domains are not met. We are very uncertain about the results. 
• No evidence: no RCTs were identified that addressed this outcome. 
Results 
Description of studies 
Results of the search 
We found 2479 titles with the electronic search (Figure 3), 13 studies with the handsearch, and 40 titles by 
searching Conference Proceedings and websites. After removing duplicates, we screened 859 titles and excluded 
706 based on titles and 10 after reviewing the abstracts. We retrieved 143 full texts. We excluded 135 studies, 
one of which because we were unable to retrieve the full paper [58]. We wrote to the principal investigators but 
they did not respond. Both Coillard 2012 [59] and Lusini 2013 [60] agreed to send the final versions of articles 
that were under review for publication. Lusini 2013 [60] has since been published. This resulted in seven 
included studies, two of which were reported in the original version of this review. Two studies are awaiting 
classification [61,62]. 
Included studies 
Seven articles met our inclusion criteria: five were planned as RCTs [59,63–66], and two as prospective 
controlled trials [60,67]. Two RCTs failed due to very low recruitment of participants [65,68]. 
The RCT by Weinstein 2013a [65] focused on 25° to 40° curves. Unfortunately, 64.7% of adolescents refused to 
participate and 21% of adolescents and their parents rejected randomization; other adolescents were lost for 
numerous reasons. The final percentage of participants that could be allocated to the randomized arm was 
10.6%, including 0.9% that crossed over groups. Due to this low inclusion rate, the authors extended the 
inclusion criteria to include adolescents with 20° curves. In addition, they transformed the study into a 
prospective controlled trial, including a randomized arm. This study was considered both as a prospective non-
randomized study with the all sample [65], and as randomized trial considering only the sub-sample that was 
randomized [69]. 
Bunge 2010 [68] aimed to recruit adolescents and compare braces with observation only; the study failed 
completely during the recruitment phase; so we excluded it from further consideration. 
Thus, we included four randomized controlled trials/arms [59,64,66,69], and three prospective controlled trials 
[60,65,67]. One controlled prospective paper had a follow-up at 16 years in a sub-group of adolescents [67]. 
Nachemson 1995 [67] was a worldwide collaboration including hospitals from two continents; they observed 
two groups of clinicians, where the first group believed in the effectiveness of treatment with a brace, and the 
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second group firmly believed that a brace was ineffective and thus managed people with careful observation; two 
centres of this last group treated adolescents with lateral electrical surface stimulation. 
Types of treatments and comparisons: Braces included elastic bands [59,66], rigid (polyethylene) [64–67,69], 
and very rigid (polycarbonate) thoraco-lumbo-sacral orthosis [60]. Two studies compared bracing with 
observation [59,65,69], one study compared bracing plus physiotherapeutic-specific scoliosis exercises versus 
observation [60]. One study compared rigid bracing with observation or electrical stimulation [67]. Two studies 
compared two different types of braces: rigid versus an elastic soft brace [66], and two different rigid braces with 
the same number of hours wearing the brace every day [64]. 
Duration of the trials: the duration was different among all included studies, with the range being between one 
and five years. Coillard 2012 [59] had a follow-up at five years post-randomization, Lou 2012 [64] had follow-
up at three years, and Lusini 2013 [60] had follow-up at two to nine years. In Nachemson 1995 [67], after being 
treated until maturity (up to four years), a subset of all Swedish adolescents were followed up for 16 years after 
treatment (range 10.9 to 19.4 years), including a braced (Malmö; 41 participants) and observed (Göteborg; 65 
participants) group. 
Participants: 662 participants were included, of these 483 were treated with a brace, 133 observed, and 46 were 
prescribed a control treatment different from bracing (electrical stimulation). Studies were not completely 
homogeneous in terms of population characteristics. The mean age was approximately 12.5 years for all studies 
except Lusini 2013 [60] (mean age above 14 years). In most studies, Cobb degrees were between 20° and 40°, 
apart from the studies of Coillard 2012 [59] (15° to 30°) and Lusini 2013 [60] (greater than 45°). The two studies 
evaluating elastic bracing focused on low degree curves (15° to 30° [59], and 20° to 30° [66], while those using 
very rigid bracing focused on very high degree curves greater than 45° [60]. Lou 2012 [64] described neither the 
Cobb angles nor the age of the participants. 
Outcomes: of the primary outcomes considered in this review, only QoL modifications due to bracing were 
considered by three papers: Weinstein 2013b [69] used the PedsQL score [70,71], Nachemson 1995 [67] used 
the SRS22 [72,73] and the 36-item Short Form (SF=36) [74,75], and Wong 2008 [66] used a purpose-designed 
questionnaire. All the studies focused on the secondary outcome, scoliosis progression. 
Countries in which the studies were conducted: one RCT was conducted in Hong Kong [66], two in Canada 
[59,64], and one was a multicentre study conducted in the US and Canada [69]. One prospective cohort study 
was a multinational study conducted in three centres in the UK, four centres in the US, one centre in Canada, and 
two centres in Sweden [67]. The other prospective study was performed in Italy [60]. 
Excluded studies 
We excluded 136 papers for the following main reasons: 45 were retrospective, 37 were prospective but without 
concurrent controls, and 53 were excluded for other reasons. Bunge 2008 [63] was an RCT, but was excluded 
from the final analysis because of the low numbers of participants that agreed to participate and be randomized. 
Allocation (selection bias) 
We judged the method of random sequence generation as low risk of bias in two RCTs [59,69]. Random 
sequence generation was unclear in the other two RCTs [64,66]. The allocation concealment was at low risk of 
bias in one RCT [59] , and unclear in the remaining studies. It was at high risk of bias in the observational 
studies. 
Blinding (performance bias and detection bias) 
Neither the RCTs nor the prospective cohort studies could be blinded for participants and providers because of 
the type of intervention assessed (brace). The risk of detection bias was high for all the studies for subjective 
outcomes (e.g. QoL or disability) and low for objective outcomes (e.g. Cobb degrees or scoliosis progression). 
The outcome assessor was not blinded in Coillard 2012 [59], and was blinded in Weinstein 2013a [65], whereas 
blinding of the assessor was not reported in all other studies. Consequently, for subjective outcomes (e.g. self 
reported pain), we judged the risk of detection bias to be high for Coillard 2012 [59], low for Weinstein 2013a 
[65], and unclear in the other studies, For objective outcomes, we rated detection bias as low because they are 
unlikely to be biased by lack of blinding. 
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Incomplete outcome data (attrition bias) 
Three RCTs reported no drop-outs [64,66,69]. We judged Coillard 2012 [59] at high risk of attrition bias because 
there was a high rate of drop-outs and this was unbalanced between groups. In two of the prospective cohort 
studies, the percentage of loss at follow-up was unbalanced between groups (21% in the experimental group and 
7% in the control group in Nachemson 1995 [67]; 7.7% in the experimental group and 44% in the control group 
in Lusini 2013 [60]). However, Lusini 2013 [60] performed an intention-to-treat (ITT) analysis with worst-case 
analysis considering loss at follow-up as a failure for the outcome 'improvement', and as a success for the 
outcome 'scoliosis progression/fusion'. Consequently, we judged this study to be at low risk of attrition bias. We 
judged the Weinstein 2013a [65] paper at low risk of bias because there was no loss at follow-up. 
Selective reporting (reporting bias) 
All studies were free of selective reporting. 
Other potential sources of bias 
In terms of group similarity at baseline, in two RCTs, groups were similar for the main prognostic factors 
[59,66], in one RCT, no information was reported about the baseline characteristics of participants [64]. In one 
prospective cohort study, the brace group had more participants with severe scoliosis, fewer participants with 
imbalance, and fewer participants with menarche at baseline compared with the electrical stimulation or 
observation-only groups [67]. Bunge 2010, Lusini 2013, and Weinstein 2013a [60,65,68] reported no 
information about the similarity or differences of participants at baseline. 
Two of the observational studies did not adjust for the most important confounding factors. Weinstein 2013a 
[65] used propensity scores to reduce the effect of treatment selection bias, so we judged this study at low risk of 
bias due to confounding. Two studies did not report information on compliance and co-interventions. Weinstein 
2013a [65] assessed compliance by temperature monitor data and self reported diary, so we judged it as being at 
low risk of bias due to non-compliance. The timing of outcome assessment was similar across groups in all 
studies. 
Effects of interventions 
1. Brace versus observation (randomized controlled trials) 
Primary outcome measures 
Pulmonary disorders, disability, back pain, psychological issues, and cosmetic issues 
No studies assessed pulmonary disorders, disability, back pain, psychological issues, and cosmetic issues. 
Quality of life 
Two years' follow-up: Weinstein 2013b [69] (111 participants) found that the mean PedsQL did not differ 
significantly between bracing and observation (MD -2.10, 95% CI -7.69 to 3.49). 
Secondary outcome measures 
Progression of scoliosis 
Two years' follow-up: Weinstein 2013b [69] found the rate of success (curves remaining below 50°) was 38/51 
in the brace group and 27/65 in the observation group (RR 1.79, 95% CI 1.29 to 2.50). The results were in favour 
of brace. 
Three years' follow-up: Coillard 2012 [59] reported the rate of success (correction or stabilization, i.e. 5° or 
less curve progression) as 21/26 in the brace group and 9/21 in the control group(RR 1.88, 95% CI 1.11 to 3.20). 
The results were in favour of brace. 
Five years' follow-up: Coillard 2012 [59]  found the rate of success was 19/26 in the brace group and 12/21 in 
the control group (RR 1.28, 95% CI 0.83 to 1.98). There was no significant difference between groups. 
Participants with curves exceeding 45º at maturity: Coillard 2012 [59]  found that 3/21 (14.3%) participants 
in the control group and 3/26 (11.5%) participants in the treated group had Cobb angles that exceeded 45° at the 
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end of study. Weinstein 2013b [69] found that 13/51 participants in the brace group and 38/65 in the observation 
group reached 50° or more at the end of growth. 
Participants who had undergone surgery or received a recommendation for surgery: Coillard 2012 
[59]  reported that 3/21 (14.3%) immature participants required surgical fusion while in the trial. The mean curve 
magnitude at the beginning of the treatment in this particular group was 27° (range 20° to 30º) and they all had a 
Risser sign of 0. In the treated group, 2/26 (7.7%) immature participants were recommended surgery during the 
study and 1/26 treated participant was recommended surgery after three years following the end of treatment. 
Adverse events 
No studies assessed adverse events. 
2. Brace versus observation or electrical stimulation (prospective cohort studies) 
Primary outcome measures 
Pulmonary disorders and disability 
No studies assessed pulmonary disorders, and disability. 
Quality of life, back pain, and psychological and cosmetic issues 
Two years' follow-up: Weinstein 2013a [65] (236 participants) reported that the mean PedsQL for all 
participants included in the study did not differ significantly between bracing and observation (MD 0.10, 95% CI 
-3.90 to 4.10). 
Long-term (16 years) follow-up: the Swedish cohort of Nachemson 1995 [67] reported 16 years' follow-up 
with 40 participants in the observation group and 37 participants in the brace group. Using the SRS22, they 
found no differences between groups for each of the sub-scales and the total score (mean (SD); pain: 4.3 (0.7) 
with observation versus 4.4 (0.6) with brace; P value = 0.94; self image/appearance: 3.9 (0.8) with observation 
versus 3.9 (0.7) with brace; P value = 0.98; function/activity: 4.5 (0.5) with observation versus 4.5 (0.5) with 
brace; P value = 0.60; mental health: 4.1 (0.7) with observation versus 4.1 (0.7) with brace; P value = 0.93; 
satisfaction with management: 3.7 (1.0) with observation versus 3.8 (0.9) with brace; P value = 0.45; total score: 
4.1 (0.5) with observation versus 4.2 (0.4) with brace; P value = 0.91). 
Similarly, there were no differences using the SF-36 (mean observation versus brace; physical functioning 94.5 
(95% CI 91.9 to 97.1) versus 94.9 (95% CI 92.1 to 97.1); P value = 0.80; role physical: 93.1 (95% CI 87.3 to 
98.9) versus 91.9 (95% CI 84.8 to 97.7); P value = 0.94; bodily pain: 75.0 (95% CI 67.4 to 82.5) versus 68.1 
(95% CI 60.2 to 74.5); P value = 0.19; general health: 83.7 (95% CI 74.6 to 88.2) versus 79.8 (95% CI 75.1 to 
83.6); P value = 0.15; vitality: 69.9 (95% CI 63.3 to 76.1) versus 68.2 (95% CI 61.6 to 73.7); P value = 0.78; 
social functioning: 91.9 (95% CI 86.7 to 97.0) versus 89.5 (95% CI 83.3 to 94.6); P value = 0.34; emotional 
aspects: 90.0 (95% CI 82.5 to 97.5) versus 86.5 (95% CI 76.5 to 94.6); P value = 0.79; mental health: 83.5 (95% 
CI 78.9 to 88.1) versus 81.3 (95% CI 76.2–85.4); P value = 0.51). 
Secondary outcome measures 
Progression of scoliosis 
Two years' follow-up: Weinstein 2013a [65] examined rate of success (curves not evolving to 50° or above) 
among 146 braced and 96 observed participants. The rate of success was in favour of the bracing group (RR 
1.50, 95% CI 1.19 to 1.89). 
Three years' follow-up: Nachemson 1995 [67] reported that the success rates (defined as less than 6° increase 
of the curve) were 80% (95% CI 66% to 88%) for bracing, 46% (95% CI 25% to 56%) for observation, and 39% 
(95% CI 19% to 59%) for electrical stimulation. When comparing brace with observation, the results favoured 
the brace group (240 participants; RR 1.75, 95% CI 1.42 to 2.16). 
Four years' follow-up: Nachemson 1995 [67] reported that the success rates were 74% (95% CI 52% to 84%) 
for bracing, 34% (95% CI 16% to 49%) for observation, and 33% (95% CI 12% to 60%) for electrical 
stimulation (log-rank test P value < 0.0001). When comparing brace with observation, the results favoured the 
brace group (240 participants; RR 2.22, 95% CI 1.70 to 2.90). A worst-case analysis for the bracing group in 
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which the 23 participants who dropped out from the brace arm were considered to have had failed treatment, 
maintained a highly significant success in preventing progression of 6° or more until skeletal maturity (log-rank 
test P value < 0.0005). 
Long-term (16 years) follow-up: Nachemson 1995 [67] found that participants braced or observed progressed 
more than 5° (range 5° to 21°). This progression meant that braced participants returned to the pre-treatment 
levels (31.9° now versus 33.0° at start). Observed participants (excluding 11 who were braced and six who were 
fused during growth because of failure) showed an overall progression from the start of treatment of 6.4° (range 
5° to 14°). 
Adverse events 
Two years' follow-up: Weinstein 2013a [65] found no difference between groups in the percentage of 
participants with any adverse event (RR 1.27, 95% CI 0.96 to 1.67) and in the percentage of participants 
reporting back pain (which was the most common adverse event) (RR 0.72, 95% CI 0.47 to 1.10;). One serious 
adverse event, a hospitalization for anxiety and depression, was reported in one participant who wore a brace. 
Adverse events involving the skin under the brace were reported in 12/146 (8%) participants who wore a brace. 
3. Brace and exercise versus observation in high-degree curves (prospective cohort study) 
Primary outcome measures 
Pulmonary disorders, disability, back pain, psychological issues, cosmetic issues, and quality of life 
The study did not assess pulmonary disorders, disability, back pain, psychological issues, cosmetic issues, and 
QoL. 
Secondary outcome measures 
Progression of scoliosis 
Two to nine years' follow up: Lusini 2013 [60] reported that the rate of success (no progression of 5° or more, 
no fusion, or no waiting list for fusion) was 25/33 in the brace group and 0/10 in observation group in the per-
protocol analysis (RR 15.21, 95% CI 1.00 to 230.23) and 31/39 in the brace group and 8/18 in the observation 
group in the ITT analysis (RR 1.79, 95% CI 1.04 to 3.07). The results were in favour of brace. 
Adverse events 
The study did not assess adverse events. 
4. Smart brace versus standard rigid brace (randomized controlled trial) 
Primary outcome measures 
Pulmonary disorders, disability, back pain, psychological issues, cosmetic issues, and quality of life 
The study did not assess pulmonary disorders, disability, back pain, psychological issues, cosmetic issues, and 
QoL. 
Secondary outcome measures 
Progression of scoliosis 
Lou 2012 [64] (12 participants) found no significant difference between the Smart brace and the standard rigid 
brace. The Cobb angles (mean ± SD) were: pre-brace 33 ± 6° with Smart brace versus 33 ± 6° with standard 
rigid brace; in brace: 20 ± 5° with Smart brace versus 21 ± 4° with standard rigid brace; three years after: 35 ± 7° 
with Smart brace versus 38 ± 9° with standard rigid brace. The in-brace correction (% of initial Cobb angle) was 
38 ± 3% with Smart brace versus 36 ± 5% with standard rigid brace. 
Five years' follow-up: risk of progression (mean ± SD): 60.2 ± 27% with Smart versus 63.4 ± 27% with 
standard rigid brace. At the end of treatment, the Cobb angle progressed by (mean ± SD) 2.2 ± 1.2° with 
Smartbrace versus 4.8 ± 8° with standard rigid brace. 
Adverse events 
The study did not assess adverse events. 
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Compliance 
The participants in the Smart brace group were more likely to wear their brace at the prescribed level during day 
time activity compared with the standard rigid group (67% with Smart brace versus 54% with standard rigid 
brace). 
5. Rigid brace versus elastic brace (randomized controlled trial) 
Primary outcome measures 
Pulmonary disorders, disability, back pain, psychological issues, and cosmetic issues 
The study did not assess pulmonary disorders, disability, back pain, psychological issues, and cosmetic issues. 
Quality of life 
While the rigid brace caused significantly more problems with heat (85% with rigid brace versus 27% with 
elastic brace), as well as difficulties with donning and doffing, the participants using the elastic braces had 
difficulties with toileting [66] (Wong 2008). 
Secondary outcome measures 
Progression of scoliosis 
Four years' follow-up: Wong 2008 [66] found that, in participants with 20° to 30° Cobb angle before skeletal 
maturity, a rigid brace showed better results than an elastic brace (SpineCor) (risk of success defined as no 
progression more than 5°: RR 1.40, 95% CI 1.03 to 1.89). 
Adverse events 
Wong 2008 [66] did not assess adverse events. 
Discussion 
Summary of main results 
Despite a comprehensive search of published and unpublished literature, we found only seven studies (one 
failed), which included 662 participants. 
We did not find any results on pulmonary disorders and disability. There was moderate quality evidence from 
one small RCT (111 participants) that QoL did not differ significantly between rigid bracing and observation 
[69]; QoL, back pain, and psychological and cosmetic issues did not change in the long term (16 years) (very 
low quality evidence) [67]. All included papers were consistent in showing that bracing prevented progression 
(secondary outcome): rigid bracing in 20° 40° curves (moderate quality evidence) [65,67,69], elastic bracing in 
15° to 30° curves (low quality evidence) [59], very rigid bracing in high degree curves above 45° (very low 
quality evidence) [60]; rigid was more successful than elastic bracing (low quality evidence) [66], and a pad 
pressure control system did not increase results (very low quality evidence) [64]. Nevertheless, due to the 
strength of evidence (from low to very low quality), further research is very likely to have an important impact 
on our confidence in the estimate of effect and is likely to change the estimate. 
No specific harms have been reported. The high rate of failure of RCTs demonstrated the huge difficulties in 
performing RCTs in a field where parents reject randomization of their children: this questions the possibility of 
consistently increasing the strength of the actual evidence. 
Overall completeness and applicability of evidence 
The current evidence about brace treatment for AIS is of low to very low quality. Until now, four RCTs have 
been performed, two comparing two types of braces [64,66], and two comparing braces versus observation 
[59,69] . In Coillard 2012 [59]  and Wong 2008 [66], participants had a range of pathology below the most 
frequent indications for bracing [1], 15-30° [59], and 20° to 30º [66]. On the contrary, in the classical range of 
25° to 40° curves [1,31] the implementation of RCTs is challenging. The members of one of the main scientific 
societies in the field, the SRS, which consists mainly of orthopaedic surgeons, were found to be in equipoise on 
bracing [51], and were able to plan an RCT [69]; conversely, members of the second main society, the 
conservative experts of SOSORT, rejected the possibility of performing an RCT [1,76,77]; they found this 
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possibility comparable to an RCT on parachutes [78]. Despite these professional positions, the strongest 
argument against the possibility of performing RCTs comes from the reality that most parents (70% to 80% of 
cases) will not allow their children to be randomized. This was the main reason for failure of the two best efforts 
performed in recent years [63,65,77]. In fact, while the Dutch RCT failed completely [68], the US trial [65], 
financed with more than USD 5 million by the US Government through the 'National Institute of Arthritis and 
Musculoskeletal and Skin Diseases', has finally been changed from an RCT to a CCT [65]. In 2013, the ethical 
committee requested that the study be stopped due to the evident success of bracing [65], and for this reason, it 
was also possible to report the RCT data. Therefore, the probability of new, future RCTs of bracing versus 
observation is low. Clinicians in this field will rely on the current low quality evidence for many years to come. 
Bunge, the main Dutch researcher (an epidemiologist) concluded, "it is harder to perform a RCT that abolishes 
or postpones a treatment than a RCT that adds a new treatment" [68]. Nevertheless, RCTs comparing different 
types or designs of braces [64,66], or different approaches have already been done and will presumably be 
performed in the future. 
Apart from the research design used by Alf Nachemson [67], the SRS Bracing Committee proposed another 
possible study design to address the methodological criteria for bracing studies [31]. Compliance and the 
standard of bracing should also be considered [76,79]. In fact, the wide range of results in brace studies [50] 
usually leads to a discussion on the methodology of the study and the type of brace used, but the quality of 
bracing and participants' management should also be considered [76,79]. These have been addressed by the 
Society on Scoliosis Orthopaedic and Rehabilitation Treatment (SOSORT) with the Guidelines on "Standards of 
management of idiopathic scoliosis with corrective braces in daily clinics and in clinical research" [76]. The SRS 
and SOSORT criteria for bracing should be considered for the methodological and management standards to be 
followed in future research studies, and will allow meta-analysis to be performed on solid methodological 
criteria. 
Other fields to be explored are the importance of compliance and methods to increase compliance [80,81]; the 
possible usefulness of physiotherapeutic scoliosis (specific or not) exercises [1,82]; means to reduce the impact 
of bracing on participants, even if according to our results there is low quality evidence that it is not different 
from observation alone [65]. 
Clinical relevance 
All included studies strongly mimic the clinical reality (high ecological and external validity). Two studies 
included only females, which reflects the fact that the majority (80% to 90%) of people with AIS are female 
[66,67]. In fact, the limit of the current evidence comes from the difficulty previously discussed in performing a 
classical RCT (high internal, but usually low external validity). 
Generally in the literature, and specifically in the retrieved studies within this review, outcomes other than Cobb 
degrees are barely considered. This reflects physicians' attitudes that during growth, their focus is on avoiding or 
at least curbing curve progression (secondary aim) to prevent future problems of QoL, disability, back pain, etc. 
(primary aims). This approach comes from the fact that scoliosis is progressive during growth, and if the curves 
surpass 30° Cobb at the end of growth, the risk of health problems in adulthood increases. Consequently, results 
reported in this review are clinically relevant, according to the current focus in the literature on Cobb degrees as 
the primary outcome. Nevertheless, the lack of focus on secondary adverse effects of treatment, as well as the 
absence of long-term, primary outcome results (QoL, disability, pain) must be stressed and addressed in future 
studies. 
No major risks of the intervention have been reported in the literature, apart from skin problems and anxiety 
[65], hot during summer with rigid bracing and difficulties in toileting with the elastic braces, that is, minor 
adverse effects [66]. 
Quality of the evidence 
Overall, the quality of evidence in favour of bracing alone or bracing plus exercise compared to observation or 
electrical stimulation is from low to very low quality. The included studies for these comparisons were two 
RCTs with only 47 and 116 participants. One RCT was at high risk of attrition bias, the other trial was at unclear 
risk of selection bias. The other included studies were three prospective cohort studies, two of which had a high 
attrition rate and no adjustment for potential confounding factors. In addition, the evidence for comparisons of 
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different types of braces is low: only two RCTs with very small sample size and a high or unclear risk of bias 
across all domains of bias. 
Note that since 80% to 90% of people with AIS are female, the inclusion of one study of only females was not 
considered to be a source of indirectness [66,67]. 
Potential biases in the review process 
The strength of the review is the extensive and comprehensive searches conducted, including many different 
sources in many languages. Another strength is its high ecological validity, due to the real-life situations 
considered in the studies. The main weakness of the review is the absence of strong studies in this field that do 
not make it possible to reach firm conclusions. Nevertheless, results among the studies included are fairly 
coherent. Two authors of this review were also authors of one of the primary studies [60]; this paper was 
evaluated by the other review authors. 
Agreements and disagreements with other studies or reviews 
The previous Cochrane review was based on two studies only [53,83]. In recent years, a number of well-
designed studies have been conducted, and as a whole, the current evidence is much stronger than that presented 
in the original review. 
One "evidence-based review" looked at entirely different outcomes from those considered here: the "rate of 
surgery" (failure of treatment) in braced groups ranged between 1.4% and 41% [50]. This paper was based on 
retrospective comparative studies, and on retrospective and prospective case series results, all of which we 
excluded from the current review. Furthermore, only papers in English were considered, while those adding 
exercises to bracing were excluded. It was not possible to obtain a good uniformity of methods and outcomes 
among papers, even if sub-group analysis was attempted. These problems could be overcome following the SRS 
criteria for bracing studies [31]. Moreover, excluding papers that add exercises to bracing should not be done in 
the future, because, according to SOSORT criteria [76], this is a management criterion to increase compliance. 
In fact, papers including exercises report very low surgery rates (2% to 7% for efficacy analysis, 10% to 14% for 
worst -case analysis), comparable to the best results in the bracing papers reported above [24,84–87]. 
Authors' conclusions 
Implications for practice 
Due to the important clinical differences among the studies, it was not possible to perform a meta-analysis. We 
found no studies reporting pulmonary disorders and disability; one study showed that bracing did not change 
quality of life (QoL) during treatment (moderate quality evidence); QoL, back pain, and psychological and 
cosmetic issues did not change in the long term (16 years) (very low quality). All included papers were 
consistent in showing that bracing avoided progression (secondary outcome). Due to the strength of evidence 
(from moderate to very low, owing to the methodological quality of the studies), a good estimate of the effect 
remains uncertain. The high rate of failure of randomized controlled trials (RCTs) demonstrates the huge 
difficulties in performing RCTs in a field where parents reject randomization of their children: this questions the 
possibility of consistently increasing the strength of the actual evidence. 
Implications for research 
Due to the difficulties in performing RCTs in this field, “expertise-based" trials, where people are randomized to 
centres acting according to their preferred protocols, are a possible option. Together with controlled prospective 
trials, another option is studies conducted according to the SRS [31] and SOSORT [76] criteria for bracing to 
allow comparability, such as prospective multicentre cohort studies or prospective case series of participants 
treated and not treated. Other similar criteria for different populations would be important to allow future meta-
studies to be performed. 
Moreover, any future study should significantly widen their focus on participant outcomes (not just radiographic 
outcomes of scoliosis progression) as well as adverse effects, so that balanced conclusions may be generated. 
Other fields to be explored are the importance of compliance and methods to increase compliance; the possible 
usefulness of physiotherapeutic exercises as well as means to reduce the impact of bracing on participants. 
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1 MEDLINE and EMBASE search strategies 
MEDLINE and MEDLINE Non-Indexed and In-Process Citations 
Last searched 17 February 2015 
1 Comparative Study/ 
2 exp Evaluation Studies/ 
3 exp Follow-Up Studies/ 
4 exp Prospective Studies/ 
5 exp Cross-Over Studies/ 
6 exp Epidemiologic Studies/ 
7 exp Case-Control Studies/ 
8 exp Cohort Studies/ 
9 exp Cross-Sectional Studies/ 
10 (cohort adj (study or studies)).mp. 
11 cohort analy$.mp. 
12 (follow up adj (study or studies)).mp. 
13 (observational adj (study or studies)).mp. 
14 longitudinal.mp. 
15 retrospective.mp. 
16 cross sectional.mp. 
17 control$.mp. 
18 prospective$.mp. 
19 volunteer.mp. 
20 or/1-19 
21 randomized controlled trial.pt. 
22 controlled clinical trial.pt. 
23 randomized.ab,ti. 
24 placebo.ab,ti. 
25 drug therapy.fs. 
26 randomly.ab,ti. 
27 trial.ab,ti. 
28 groups.ab,ti. 
29 or/21-27 
30 (animals not (humans and animals)).sh. 
31 29 not 30 
32 Animals/ 
33 Humans/ 
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34 32 not (32 and 33) 
35 29 not 34 
36 20 not 34 
37 35 or 36 or 31 
38 exp Spinal Diseases/ 
39 exp Scoliosis/ 
40 scoliosis.mp. 
41 or/38-40 
42 exp Braces/ 
43 brace$.mp. 
44 bracing.mp. 
45 exp Orthotic Devices/ 
46 exp Orthopedic Equipment/ 
47 limit 46 to yr="1902 - 1975" 
48 or/42-45 
49 47 or 48 ( 
50 exp Adolescent/ 
51 adolescen$.mp. 
52 50 or 51 
53 41 and 48 and 52 
54 37 and 53 
55 limit 54 to yr=2013-2015 
56 limit 54 to ed=20131009-20150217 
57 55 or 56 
EMBASE 
Last searched 17 February 2015. For this search, the animal study filter was updated and line 51 was changed 
from 34 and 51 to 34 or 51. See previous strategy below. 
1 exp Clinical Study/ 
2 exp Case Control Study/ 
3 exp Family Study/ 
4 exp Longitudinal Study/ 
5 exp Retrospective Study/ 
6 exp Prospective Study/ 
7 exp Cohort Analysis/ 
8 (cohort adj (study or studies)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] 
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9 (case control adj (study or studies)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] 
10 (follow up adj (study or studies)).mp. [mp=title, abstract, subject headings, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, keyword] 
11 (observational adj (study or studies)).mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 
12 (epidemiologic$ adj (study or studies)).mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 
13 (cross sectional adj (study or studies)).mp. [mp=title, abstract, subject headings, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 
14 exp Comparative Study/ 
15 evaluation study.mp. 
16 follow-up study.mp. or exp Follow Up/ 
17 Crossover Procedure/ 
18 prospective$.mp. 
19 exp VOLUNTEER/ 
20 or/1-19 
21 Clinical Article/ 
22 exp Clinical Study/ 
23 Clinical Trial/ 
24 Controlled Study/ 
25 Randomized Controlled Trial/ 
26 Major Clinical Study/ 
27 Double Blind Procedure/ 
28 Multicenter Study/ 
29 Single Blind Procedure/ 
30 Phase 3 Clinical Trial/ 
31 Phase 4 Clinical Trial/ 
32 crossover procedure/ 
33 placebo/ 
34 or/21-33 
35 allocat$.mp. 
36 assign$.mp. 
37 blind$.mp. 
38 (clinic$ adj25 (study or trial)).mp. 
39 compar$.mp. 
40 control$.mp. 
41 cross?over.mp. 
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42 factorial$.mp. 
43 follow?up.mp. 
44 placebo$.mp. 
45 prospectiv$.mp. 
46 random$.mp. 
47 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).mp. 
48 trial.mp. 
49 (versus or vs).mp. 
50 or/35-49 
51 34 or 50 
52 20 or 51 
53 exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or 
nonhuman/ 
54 human/ or normal human/ or human cell/ 
55 53 and 54 
56 53 not 55 
57 52 not 56 
58 exp SPINE/ 
59 exp Spine Disease/ 
60 exp SCOLIOSIS/ 
61 exp Idiopathic Scoliosis/ 
62 scoliosis.mp. 
63 or/58-62 
64 exp Brace/ 
65 brace$.mp. 
66 bracing.mp. 
67 exp ORTHOTICS/ 
68 exp orthopedic equipment/ 
69 or/64-68 
70 Adolescent/ 
71 adolescen#.mp. 
72 70 or 71 
73 63 and 69 and 72 
74 57 and 73 
75 limit 74 to yr=2013-2015 
76 limit 74 to em=201340-201507 
77 75 or 76 
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Previous search strategy for 2012 and 2013 
1 exp Clinical Study/ 
2 exp Case Control Study/ 
3 exp Family Study/ 
4 exp Longitudinal Study/ 
5 exp Retrospective Study/ 
6 exp Prospective Study/ 
7 exp Cohort Analysis/ 
8 (cohort adj (study or studies)).mp. 
9 (case control adj (study or studies)).mp. 
10 (follow up adj (study or studies)).mp. 
11 (observational adj (study or studies)).mp. 
12 (epidemiologic$ adj (study or studies)).mp. 
13 (cross sectional adj (study or studies)).mp. 
14 exp Comparative Study/ 
15 evaluation study.mp. 
16 follow-up study.mp. or exp Follow Up/ 
17 Crossover Procedure/ 
18 prospective$.mp. 
19 exp VOLUNTEER/ 
20 or/1-19 
21 Clinical Article/ 
22 exp Clinical Study/ 
23 Clinical Trial/ 
24 Controlled Study/ 
25 Randomized Controlled Trial/ 
26 Major Clinical Study/ 
27 Double Blind Procedure/ 
28 Multicenter Study/ 
29 Single Blind Procedure/ 
30 Phase 3 Clinical Trial/ 
31 Phase 4 Clinical Trial/ 
32 crossover procedure/ 
33 placebo/ 
34 or/21-33 
35 allocat$.mp. 
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36 assign$.mp. 
37 blind$.mp. 
38 (clinic$ adj25 (study or trial)).mp. 
39 compar$.mp. 
40 control$.mp. 
41 cross?over.mp. 
42 factorial$.mp. 
43 follow?up.mp. 
44 placebo$.mp. 
45 prospectiv$.mp. 
46 random$.mp. 
47 ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).mp. 
48 trial.mp. 
49 (versus or vs).mp. 
50 or/35-49 
51 34 and 50 
52 20 or 51 
53 Human/ 
54 Nonhuman/ 
55 exp ANIMAL/ 
56 Animal Experiment/ 
57 54 or 55 or 56 
58 53 not 57 
59 52 not 57 
60 58 or 59 
61 exp SPINE/ 
62 exp Spine Disease/ 
63 exp SCOLIOSIS/ 
64 exp Idiopathic Scoliosis/ 
65 scoliosis.mp. 
66 or/61-65 
67 exp Brace/ 
68 brace$.mp. 
69 bracing.mp. 
70 exp ORTHOTICS/ 
71 exp orthopedic equipment/ 
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72 or/67-71 
73 Adolescent/ 
74 adolescen#.mp. 
75 73 or 74 
76 66 and 72 and 75 
77 52 and 76 
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2 CENTRAL and CINAHL search strategies 
CENTRAL 
Last searched 17 February 2015. 
#1 MeSH descriptor: [Scoliosis] this term only 
#2 scoliosis 
#3 #1 or #2 
#4 MeSH descriptor: [Braces] this term only 
#5 braces in Trials 
#6 bracing in Trials 
#7 #4 or #5 or #6 
#8 #3 and #7 
#9 #8 Publication Year from 2013 to 2015, in Trials 
CINAHL 
Last searched 18 February 2015. 
S14 S13 Limiters - Published Date: 20131001-20150231 
S13 S12 and S9 and S5 
S12 S11 or S10 
S11 adolescen* 
S10 (MH "Adolescence+") 
S9 S8 or S7 or S6 
S8 "bracing*" 
S7 "brace*" 
S6 (MH "Orthoses+") 
S5 S4 or S3 or S2 or S1 
S4 "scoliosis" 
S3 (MH "Scoliosis") 
S2 (MH "Spinal Diseases+") 
S1 (MH "Spine+") 
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3 PsycINFO, PEDro, Back Group Trials Register, clinical trials registries, and PubMed search strategies 
PsycINFO 
Last searched 17 February 2015. 
1. scoliosis.mp. 
2. braces.mp. 
3. bracing.mp. 
4. 2 or 3 
5. 1 and 4 
6. limit 5 to yr=2013-2015 
PEDro 
Last searched 17 February 2015. For this search, the method section was left blank. In the previous searches in 
2012 and 2013, the method section was limited to clinical trial. 
Abstract & Title: scoliosis 
AND 
Method: left blank 
AND 
Published since: 2013 
Back Group's Trials Register 
Cochrane Register of Studies (CRS) 
Last searched 18 February 2015. The purpose of this search was to identify studies not in CENTRAL, therefore 
only studies not in CENTRAL and dated 2013 and onward were selected. 
#1 (scoliosis AND brac*) AND (INREGISTER) 
Reference Manager 
2012: All non-indexed text fields: (scoliosis AND brac*), published since 2008 
ClinicalTrials.gov 
Last searched 17 February 2015. 
Search term: scoliosis 
AND 
Intervention: brace or bracing 
AND received from 10/10/2013 to 02/17/2015 
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WHO ICTRP 
Last searched 17 February 2015. 
Title: brace or bracing 
AND 
Condition: scoliosis 
Date of registration is between 01/10/2013-17/02/2015 
PubMed 
Last searched 17 February 2015. 
((((braces or bracing))) AND scoliosis) AND ("2013/10/01"[Date - Publication] : "3000"[Date - Publication]) 
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